EW vs LPCN · P/E 47, rev $3.39B vs rev $309.5K
Edwards Lifesciences Corp (EW) versus Lipocine Inc (LPCN) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Latest reported EW revenue for 2026-06-30 was $3.39B. Net income was $622.6M. EW currently screens at market cap $49.91B and trailing P/E 46.9.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
EW currently screens at market cap $49.91B and trailing P/E 46.9. LPCN currently screens at market cap $19.3M.
Not investment advice. Open the EW and LPCN stock pages for the full models.
Not investment advice.